The Union home ministry has started the process for eviction and sale of enemy properties, the immovable assets left behind by people who have taken citizenship of Pakistan and China. IMAGE:......
The country's first indigenous mRNA vaccine candidate developed by Gennova, Pune has received approval from drug regulators to initiate Phase 1/2 human clinical trials, the Department of......
World Health Organisation (WHO) chief Tedros Adhanom Ghebreyesus on Wednesday thanked Union Health Minister Mansukh Mandaviya for announcing resumption of COVID-19 vaccine shipments to the COVAX......
India will resume export of surplus COVID-19 vaccines next month under the 'Vaccine Maitri' programme and to meet its commitment to the COVAX global pool, but vaccinating its own citizens remains......
By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.The vaccine, named PTX-COVID19-B, is under development in Canada and......
Serum Institute of India plans to make 300 million doses of AZD1222 by December, and will begin phase-2 trials soon. It has also tied up with Novavax for development and commercialisation of its......
Coal India achieved a staggering production of 536.51 million tonnes during the financial year ended March 31, 2016 When Union coal and power minister Piyush Goyal set a target of providing......
A chunk of divestment till now has come from follow-on offerings in the Centre’s two ETFs, Bharat-22 and CPSE. Now, there will be initial public offerings of Mazagon Docks, rail companies......